What Is the First-Line Treatment for Burning Mouth Syndrome?

Clinical Context

Burning Mouth Syndrome is characterised by chronic oral burning pain. This protocol addresses the first-line management of the condition, drawing on interventions evaluated in randomised controlled trials.

Treatment Goal

A clinically meaningful reduction in oral burning pain — measured by patient-reported pain scores (VAS/VNS) — sustained across both short-term (up to 3 months) and long-term (>3 months) follow-up.

First-Line Approach

Randomised trial evidence supports several first-line alternatives with strong effect sizes (SMD > 1.000) for oral pain reduction, spanning both behavioural and topical therapeutic modalities.

The complete regimen — including which specific interventions qualify, how they are applied, and how they compare — is detailed in the full structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1177/03331024211036152

The statistical analysis on the RCTs comparing intervention with placebo suggests a strong favourable outcome (SMD > 1.000) for cognitive behavioural therapy, capsaicin, topical clonazepam, and laser therapy (highest to lowest) in both short- and long-term assessment.

View source ↗